HOUSTON, TX Sept. 4, 2008. Pharm-Olam International (POI) a multi-national, full service CRO to the pharmaceutical and biotech industries reported today net service revenue growth of 47% for the first half of 2008 vs. the comparative period in 2007. “POI's strong revenues during the first half of 2008 are due to the record sales achieved during 2007 and the earlier part of this year”, said Iain Gordon, VP of Global Business Development. “We are on track for another year of record sales.”
